(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 4.79% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Albemarle's revenue in 2025 is $5,093,671,000.On average, 7 Wall Street analysts forecast ALB's revenue for 2025 to be $572,356,692,056, with the lowest ALB revenue forecast at $540,718,966,551, and the highest ALB revenue forecast at $591,872,166,573. On average, 8 Wall Street analysts forecast ALB's revenue for 2026 to be $626,750,626,632, with the lowest ALB revenue forecast at $569,169,375,556, and the highest ALB revenue forecast at $711,260,225,130.
In 2027, ALB is forecast to generate $693,065,729,694 in revenue, with the lowest revenue forecast at $604,467,649,756 and the highest revenue forecast at $766,222,814,904.